Replies to post #17293 on Seelos Therapeutics Inc (SEEL)

[SocialBoom]

It's total garbage that there is no product video on the Apricus website or on a YouTube channel dedicated to product knowledge videos.

I,would advise yo guys to knock it off trying to take it upon yourselves to inform the Urologists. You are more likely to make an enemy of our product. I doubt seriously he would appreciate product knowledge from a bunch of yahoos even if you are correct.


If you want to be productive start screaming at IR and Pascoe about this obvious and glaring problem.

[RVL]

So, a Dutch Urologist with a twitter account not aware of the dosage form and pharmacokinetic ramifications of a drug approved for usage only in England equals failure?
I want the world to be aware of this drug/stock but geez.
Ask yourself a few questions.

Who should be educating / detailing docs as individuals?
APRI?
Or the company that is selling the drug in the country approved?
Should they be doing this world wide or with physicians that can actually write a prescription for an individual patient?


From the Stockholm European Urology conference in April:

A new paradigm in the treatment of ED - the topical option
Sponsored by APRICUS BIOSCIENCES
Session type:
Symposium
Info:
Friday, 11 April 2014, 16:15 to 17:45, Room K2
Chair(s):J.P. Mulhall, New York (US)
Understanding the ED patient
Duration:16:15 - 16:35
Speaker:Y. Reisman, Amstelveen (NL)
The clinical care pathway in the management of the ED patient
Duration:16:35 - 16:55
Speaker:F. Giuliano, Garches (FR)
Vitaros: A novel strategy for ED management
Duration:16:55 - 17:15
Speaker:E. Kim, Knoxville (US)
Case studies and discussions
Duration:17:15 - 17:45
Speaker:J.P. Mulhall, New York (US)

[Dimitrios George]

Dave, you wrote:

A simple mailing to the urologists in the EU and we wouldn't have to babysit every single doc that's misinformed via twitter!

I agree. It may be that informational mailers to EU urologists must be sent by the company with marketing authorization in the country where they practice. Those companies might be waiting for their respective launches. In the UK, we don't know exactly what Takeda has done beyond what we have seen. What we have seen looks good. Takeda may have an email list of urologists and other physicians and perhaps they have already pointed to their website. I would hope so.

[eicoman]

I wouldn't jump to that conclusion yet, this doc is in Holland which is Sandoz's responsibility, they will reach out with their launch,

Takeda is talking to the UK urologists only at this point, and I'm sure Takeda's has a great sales team

I spoke with Angeli recently and got the feeling she is doing a good job, and she feels that pascoe has been getting alot done and will continue to, her focus is getting institutional support, which has increased recently